Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dwarfism
Research
Drug lengthens limb bones in Robinow syndrome
Scientists may have found a way to intervene on some aspects of Robinow syndrome disorders before they have a chance to fully develop.
Helen Floersh
Feb 17, 2023 4:01pm
Gene therapy player InnoSkel debuts with €20M
Dec 14, 2020 8:50am
BioMarin nabs FDA review for dwarfism drug vosoritide
Nov 4, 2020 9:52am
BioMarin's dwarfism drug clears phase 3, poised for 2021 launch
Dec 16, 2019 8:42pm
Pfizer offers $340M upfront to buy Therachon for dwarfism drug
May 8, 2019 8:14am
Novo powers rare disease startup Therachon to $60M round
Aug 9, 2018 10:35am